Attached files
| file | filename |
|---|---|
| EX-31.2 - EX-31.2 - CytomX Therapeutics, Inc. | ctmx-ex312_498.htm |
| EX-32.1 - EX-32.1 - CytomX Therapeutics, Inc. | ctmx-ex321_499.htm |
| EX-31.1 - EX-31.1 - CytomX Therapeutics, Inc. | ctmx-ex311_497.htm |
| 10-K - 10-K - CytomX Therapeutics, Inc. | ctmx-10k_20151231.htm |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in the Registration Statement on Form S-8 (No. 333-207694) of CytomX Therapeutics, Inc. of our report dated March 7, 2016 relating to the financial statements, which appears in this Form 10‑K.
/s/ PricewaterhouseCoopers LLP
San Jose, California
March 7, 2016